vs
Side-by-side financial comparison of APTARGROUP, INC. (ATR) and Calumet, Inc. (CLMT). Click either name above to swap in a different company.
Calumet, Inc. is the larger business by last-quarter revenue ($1.0B vs $962.7M, roughly 1.1× APTARGROUP, INC.). APTARGROUP, INC. runs the higher net margin — 7.7% vs -3.6%, a 11.3% gap on every dollar of revenue. Calumet, Inc. produced more free cash flow last quarter ($103.8M vs $96.9M).
AptarGroup, Inc., also known as Aptar, is a United States–based global manufacturer of consumer dispensing packaging and drug delivery devices. The group has manufacturing operations in 18 countries.
Calumet, Inc. is a U.S.-headquartered specialty products firm that manufactures and distributes high-value hydrocarbon and specialty chemical products. Its offerings include specialty oils, lubricants, waxes, and renewable fuel solutions, serving industrial, consumer, and transportation segments across North America.
ATR vs CLMT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $962.7M | $1.0B |
| Net Profit | $74.3M | $-37.3M |
| Gross Margin | — | -0.3% |
| Operating Margin | 11.0% | -6.2% |
| Net Margin | 7.7% | -3.6% |
| Revenue YoY | 13.5% | — |
| Net Profit YoY | -26.4% | — |
| EPS (diluted) | $1.13 | $-0.43 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $962.7M | $1.0B | ||
| Q3 25 | $961.1M | $1.1B | ||
| Q2 25 | $966.0M | $1.0B | ||
| Q1 25 | $887.3M | $993.9M | ||
| Q4 24 | $848.1M | — | ||
| Q3 24 | $909.3M | $1.1B | ||
| Q2 24 | $910.1M | $1.1B | ||
| Q1 24 | $915.4M | — |
| Q4 25 | $74.3M | $-37.3M | ||
| Q3 25 | $127.9M | $313.4M | ||
| Q2 25 | $111.7M | $-147.9M | ||
| Q1 25 | $78.8M | $-162.0M | ||
| Q4 24 | $100.9M | — | ||
| Q3 24 | $100.0M | $-100.6M | ||
| Q2 24 | $90.5M | $-39.1M | ||
| Q1 24 | $83.1M | — |
| Q4 25 | — | -0.3% | ||
| Q3 25 | — | 34.7% | ||
| Q2 25 | — | -4.2% | ||
| Q1 25 | — | -8.2% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.4% | ||
| Q2 24 | — | 5.6% | ||
| Q1 24 | — | — |
| Q4 25 | 11.0% | -6.2% | ||
| Q3 25 | 14.2% | 30.0% | ||
| Q2 25 | 14.9% | -9.8% | ||
| Q1 25 | 12.8% | -4.9% | ||
| Q4 24 | 14.2% | — | ||
| Q3 24 | 15.2% | -5.2% | ||
| Q2 24 | 13.8% | 0.5% | ||
| Q1 24 | 12.2% | — |
| Q4 25 | 7.7% | -3.6% | ||
| Q3 25 | 13.3% | 29.1% | ||
| Q2 25 | 11.6% | -14.4% | ||
| Q1 25 | 8.9% | -16.3% | ||
| Q4 24 | 11.9% | — | ||
| Q3 24 | 11.0% | -9.1% | ||
| Q2 24 | 9.9% | -3.4% | ||
| Q1 24 | 9.1% | — |
| Q4 25 | $1.13 | $-0.43 | ||
| Q3 25 | $1.92 | $3.61 | ||
| Q2 25 | $1.67 | $-1.70 | ||
| Q1 25 | $1.17 | $-1.87 | ||
| Q4 24 | $1.48 | — | ||
| Q3 24 | $1.48 | $-1.18 | ||
| Q2 24 | $1.34 | $-0.48 | ||
| Q1 24 | $1.23 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $409.5M | $125.1M |
| Total DebtLower is stronger | $1.1B | $2.1B |
| Stockholders' EquityBook value | $2.7B | $-732.7M |
| Total Assets | $5.3B | $2.7B |
| Debt / EquityLower = less leverage | 0.43× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $409.5M | $125.1M | ||
| Q3 25 | $264.8M | $94.6M | ||
| Q2 25 | $169.8M | $110.6M | ||
| Q1 25 | $136.8M | $123.4M | ||
| Q4 24 | $226.2M | — | ||
| Q3 24 | $327.9M | $34.6M | ||
| Q2 24 | $223.9M | $7.0M | ||
| Q1 24 | $201.1M | — |
| Q4 25 | $1.1B | $2.1B | ||
| Q3 25 | $546.0M | $2.1B | ||
| Q2 25 | $535.1M | $2.1B | ||
| Q1 25 | $561.2M | $2.3B | ||
| Q4 24 | $688.1M | — | ||
| Q3 24 | $822.7M | $1.7B | ||
| Q2 24 | $681.5M | — | ||
| Q1 24 | $680.4M | — |
| Q4 25 | $2.7B | $-732.7M | ||
| Q3 25 | $2.8B | $-695.3M | ||
| Q2 25 | $2.7B | $-1.0B | ||
| Q1 25 | $2.5B | $-862.3M | ||
| Q4 24 | $2.5B | — | ||
| Q3 24 | $2.5B | $-672.2M | ||
| Q2 24 | $2.4B | $-566.4M | ||
| Q1 24 | $2.3B | — |
| Q4 25 | $5.3B | $2.7B | ||
| Q3 25 | $5.1B | $2.7B | ||
| Q2 25 | $4.9B | $2.8B | ||
| Q1 25 | $4.5B | $2.8B | ||
| Q4 24 | $4.4B | — | ||
| Q3 24 | $4.6B | $2.6B | ||
| Q2 24 | $4.5B | $100 | ||
| Q1 24 | $4.4B | — |
| Q4 25 | 0.43× | — | ||
| Q3 25 | 0.20× | — | ||
| Q2 25 | 0.20× | — | ||
| Q1 25 | 0.22× | — | ||
| Q4 24 | 0.28× | — | ||
| Q3 24 | 0.32× | — | ||
| Q2 24 | 0.28× | — | ||
| Q1 24 | 0.29× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $183.7M | $116.5M |
| Free Cash FlowOCF − Capex | $96.9M | $103.8M |
| FCF MarginFCF / Revenue | 10.1% | 10.0% |
| Capex IntensityCapex / Revenue | 9.0% | 1.2% |
| Cash ConversionOCF / Net Profit | 2.47× | — |
| TTM Free Cash FlowTrailing 4 quarters | $299.6M | $56.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $183.7M | $116.5M | ||
| Q3 25 | $177.6M | $23.5M | ||
| Q2 25 | $126.0M | $-1.8M | ||
| Q1 25 | $82.7M | $-29.3M | ||
| Q4 24 | $178.2M | — | ||
| Q3 24 | $229.3M | $-15.5M | ||
| Q2 24 | $143.6M | — | ||
| Q1 24 | $92.3M | — |
| Q4 25 | $96.9M | $103.8M | ||
| Q3 25 | $114.3M | $15.1M | ||
| Q2 25 | $62.5M | $-15.4M | ||
| Q1 25 | $25.9M | $-46.9M | ||
| Q4 24 | $112.2M | — | ||
| Q3 24 | $162.7M | $-32.2M | ||
| Q2 24 | $75.4M | — | ||
| Q1 24 | $16.7M | — |
| Q4 25 | 10.1% | 10.0% | ||
| Q3 25 | 11.9% | 1.4% | ||
| Q2 25 | 6.5% | -1.5% | ||
| Q1 25 | 2.9% | -4.7% | ||
| Q4 24 | 13.2% | — | ||
| Q3 24 | 17.9% | -2.9% | ||
| Q2 24 | 8.3% | — | ||
| Q1 24 | 1.8% | — |
| Q4 25 | 9.0% | 1.2% | ||
| Q3 25 | 6.6% | 0.8% | ||
| Q2 25 | 6.6% | 1.3% | ||
| Q1 25 | 6.4% | 1.8% | ||
| Q4 24 | 7.8% | — | ||
| Q3 24 | 7.3% | 1.5% | ||
| Q2 24 | 7.5% | 2.2% | ||
| Q1 24 | 8.3% | — |
| Q4 25 | 2.47× | — | ||
| Q3 25 | 1.39× | 0.07× | ||
| Q2 25 | 1.13× | — | ||
| Q1 25 | 1.05× | — | ||
| Q4 24 | 1.77× | — | ||
| Q3 24 | 2.29× | — | ||
| Q2 24 | 1.59× | — | ||
| Q1 24 | 1.11× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ATR
| Pharma Segment | $833.1M | 87% |
| Other | $129.6M | 13% |
CLMT
| Specialty Products And Solutions | $675.9M | 65% |
| Montana Renewables | $294.2M | 28% |
| Performance Brands | $68.5M | 7% |
